Eurofins Integrated Discovery UK Ltd is a leading provider of contract research services in drug discovery to the pharmaceutical and biotechnology industries as well as academic institutions, charities and not-for-profit organisations. Eurofins Integrated Discovery exclusively offer a Peptidyl-Prolyl-Isomerase (cyclophilin, FKBP and pin1) Profiling Portfolio that includes both binding and functional assays. In addition we offer cell-based assays to assess mitochondrial function and death, and cell-based models for Parkinson’s disease. We specifically provide expertise, resource and project management of integrated drug discovery services, including medicinal and synthetic chemistry, biology and ADME, as required to accelerate early drug discovery customer projects and deliver preclinical drug candidates. The highly industry experienced Eurofins Integrated Discovery team has a 100% track record of delivering preclinical candidates for our customers, with a number entering the clinic most recently. In addition, Eurofins Integrated Discovery scientists provide innovative solutions to customer drug discovery projects as proven by their co-authorship on >100 patents and publications. Furthermore, Eurofins Integrated Discovery assists academic groups and biotechnology companies with scientific expertise to support grant applications; to date Eurofins Integrated Discovery has helped such groups to receive a total of over $10 million funding to initiate and advance their drug discovery projects